Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-
B–Dependent Pathway
Circulation Li et al.
116: 1577
Data Supplement
Files in this Data Supplement:
- Figure I
-
(Adobe Acrobat) (213 KB). COX-1 protein content in myocardium after iNOS gene transfer. Both nontransgenic (NTg) and IκBαS32A,S36A transgenic (IκBαS32A,S36A Tg) mice received Av3/LacZ or Av3/iNOS gene transfer 3 days prior to immunoblotting analyses. The kidney served as a positive control for COX-1 protein expression. There was no change in COX-1 protein levels in the transduced myocardium after iNOS gene transfer either in NTg or IκBαS32A,S36A Tg mice (n=4/group). Assays were performed in triplicate.
- Figure II
-
(Adobe Acrobat) (386 KB). COX-2 protein content in lung, liver, spleen, and kidney after intramyocardial iNOS gene transfer. NTg, nontransgenic mice; IκBαS32A,S36ATg, IκBαS32A,S36A transgenic mice (n=6/group). Assays were performed in duplicate.